(Q30586618)

25 June 2017

1 reference

title

An integrated strategy for evaluation of metabolic and oxidative defects in neurodegenerative illness using magnetic resonance techniques (English)

1 reference

25 June 2017

1 reference

Jenkins BG

1

1 reference

25 June 2017

Chen YI

2

1 reference

25 June 2017

Kuestermann E

3

1 reference

25 June 2017

Makris NM

4

1 reference

25 June 2017

Nguyen TV

5

1 reference

25 June 2017

Kraft E

6

1 reference

25 June 2017

Brownell AL

7

1 reference

25 June 2017

Rosas HD

8

1 reference

25 June 2017

Kennedy DN

9

1 reference

25 June 2017

Rosen BR

10

1 reference

25 June 2017

Koroshetz WJ

11

1 reference

25 June 2017

Beal MF

12

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

Annals of the New York Academy of Sciences

25 June 2017

published in

1 reference

25 June 2017

volume

893

1 reference

25 June 2017

page(s)

214-242

1 reference

Characterizing the target of acute stroke therapy

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Aging, energy, and oxidative stress in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Glyceraldehyde 3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

NMR determination of the TCA cycle rate and alpha-ketoglutarate/glutamate exchange rate in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Localized in vivo 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Mitochondrial defect in Huntington's disease caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Oxidative stress and apoptosis in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Mitochondrial dysfunction in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Oxidative stress and the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Occupational exposures to metals as risk factors for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Iron induces degeneration of nigrostriatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

MRI, brain iron and experimental Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Magnetic resonance imaging of the midbrain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

T2 relaxation time in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

T2 values in the human brain: comparison with quantitative assays of iron and ferritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Magnetic resonance imaging of brain iron in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

The history of iron in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Production of superoxide anions by a CNS macrophage, the microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

In vivo magnetic resonance spectroscopy of human fetal neural transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Diffusion tensor MR imaging of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

A functional MRI study of subjects recovered from hemiparetic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Plasticity of language-related brain function during recovery from stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Biological markers in the diagnosis and treatment of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Diffusion tensor MRI assesses corticospinal tract damage in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Aspects of human bioenergetics as studied in vivo by magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronalactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Calibrated functional MRI: mapping the dynamics of oxidative metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07828.X

10.1111/J.1749-6632.1999.TB07828.X

21 January 2018

Identifiers

DOI

1 reference

25 June 2017

1 reference